Observational studyNature communications2026

Cardiovascular outcome of glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitor on end-stage kidney disease patients with heart failure: an emulated target trial in patients with diabetes.

Po-Yi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.